ASH Annual Meeting

Roche Presents Promising Data on Innovative Lymphoma Treatments at ASH Annual Meeting

(IN BRIEF) Roche, a global pharmaceutical company, has shared compelling data from its CD20xCD3 T-cell engaging bispecific antibody program during…

5 months ago

AstraZeneca Showcases Hematology Advancements and Calquence’s Long-Term Efficacy at ASH Annual Meeting

(IN BRIEF) AstraZeneca is set to unveil promising data at the 65th American Society of Hematology (ASH) Annual Meeting, highlighting…

5 months ago